553 related articles for article (PubMed ID: 2905529)
1. Dopamine receptors and the dopamine hypothesis of schizophrenia.
Seeman P
Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
[TBL] [Abstract][Full Text] [Related]
2. Novel pharmacological approaches to the treatment of schizophrenia.
Fink-Jensen A
Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
[TBL] [Abstract][Full Text] [Related]
3. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
Seeman P
Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D4 receptors elevated in schizophrenia.
Seeman P; Guan HC; Van Tol HH
Nature; 1993 Sep; 365(6445):441-5. PubMed ID: 8413587
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic treatment of patients with schizophrenia. Mechanisms of action and clinical significance.
Wiesel FA
Br J Psychiatry Suppl; 1994 Apr; (23):65-70. PubMed ID: 7913610
[TBL] [Abstract][Full Text] [Related]
6. Abnormal neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
[TBL] [Abstract][Full Text] [Related]
7. Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action.
Reynolds GP; Rossor MN; Iversen LL
J Neural Transm Suppl; 1983; 18():273-7. PubMed ID: 6135746
[TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotics: mechanism of action.
Seeman P
Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
[TBL] [Abstract][Full Text] [Related]
9. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases.
Seeman P; Bzowej NH; Guan HC; Bergeron C; Reynolds GP; Bird ED; Riederer P; Jellinger K; Tourtellotte WW
Neuropsychopharmacology; 1987 Dec; 1(1):5-15. PubMed ID: 2908095
[TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor pharmacology.
Seeman P; Van Tol HH
Curr Opin Neurol Neurosurg; 1993 Aug; 6(4):602-8. PubMed ID: 8104554
[TBL] [Abstract][Full Text] [Related]
11. Antimanic potency of typical neuroleptic drugs and affinity for dopamine D2 and serotonin 5-HT2A receptors--a new analysis of data from the archives and implications for improved antimanic treatments.
Harrison-Read PE
J Psychopharmacol; 2009 Nov; 23(8):899-907. PubMed ID: 18635692
[TBL] [Abstract][Full Text] [Related]
12. Dopamine receptors in the central nervous system.
Seeman P; Tedesco JL; Lee T; Chau-Wong M; Muller P; Bowles J; Whitaker PM; McManus C; Tittler M; Weinreich P; Friend WC; Brown GM
Fed Proc; 1978 Feb; 37(2):131-6. PubMed ID: 414936
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic receptor-blocking concentrations of neuroleptics.
Seeman P
Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():5-13. PubMed ID: 8866760
[TBL] [Abstract][Full Text] [Related]
14. Dopamine receptor genes: new tools for molecular psychiatry.
Niznik HB; Van Tol HH
J Psychiatry Neurosci; 1992 Oct; 17(4):158-80. PubMed ID: 1450188
[TBL] [Abstract][Full Text] [Related]
15. Dopamine D2-like sites in schizophrenia, but not in Alzheimer's, Huntington's, or control brains, for [3H]benzquinoline.
Seeman P; Guan HC; Nobrega J; Jiwa D; Markstein R; Balk JH; Picetti R; Borrelli E; Van Tol HH
Synapse; 1997 Feb; 25(2):137-46. PubMed ID: 9021894
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.
Seeman P
Neuropsychopharmacology; 1992 Dec; 7(4):261-84. PubMed ID: 1362057
[TBL] [Abstract][Full Text] [Related]
17. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
Joyce JN; Lexow N; Bird E; Winokur A
Synapse; 1988; 2(5):546-57. PubMed ID: 2973147
[TBL] [Abstract][Full Text] [Related]
18. Dopamine receptors and psychiatric drug treatment.
Syvälahti EK
Ann Clin Res; 1988; 20(5):340-7. PubMed ID: 2905878
[TBL] [Abstract][Full Text] [Related]
19. Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains.
Noga JT; Hyde TM; Herman MM; Spurney CF; Bigelow LB; Weinberger DR; Kleinman JE
Synapse; 1997 Nov; 27(3):168-76. PubMed ID: 9329152
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina.
Hensler JG; Cotterell DJ; Dubocovich ML
J Pharmacol Exp Ther; 1987 Dec; 243(3):857-67. PubMed ID: 2961878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
